机器学习辅助设计的树突状细胞纳米疫苗,可诱导针对猴痘的双重免疫应答
Machine learning-assisted design of a dendritic cell nanovaccine inducing twin immunity against monkeypox
Lu Yang, Xingyu Xu, Yanrong Gao, Zhiwen Gu, Yi Zhang, Sishi Lv, Abbaskhan Turaev, Huiyuan Wang, Yongzhuo Huang
Journal:JOURNAL OF CONTROLLED RELEASE
IF:12.4
DOI:10.1016/j.jconrel.2026.115311
PMID:42660460
Published:2026-08-27
research field:线粒体生物学分子生物学细胞生物学氧化应激炎症研究重症医学生物化学干细胞治疗呼吸病学
Abstract
The global emergence of monkeypox virus (MPXV) has created an urgent need for effective vaccines that induce robust immune responses. Here, we report a biomimetic nano-vaccine platform based on engineered dendritic cell membrane vesicles displaying M1R (M1R-CMVs), designed via genetic engineering with machine learning-assisted preliminary screening of physicochemical parameters including particle size (∼190 nm) and zeta potential (−18 mV). Subcutaneous delivery of M1R-CMVs with CpG adjuvant induced high titers of M1R-specific IgG and potent neutralizing antibodies. The vaccine promoted broad T cell activation, characterized by enhanced CD4 + and CD8 + T cell responses in spleen and lymph nodes, and established durable T cell memory. In vitro studies demonstrated that M1R-CMVs enhance dendritic cell maturation and T cell proliferation. Prime-boost immunization further amplified both humoral and cellular immunity, with significant increases in neutralizing antibody titers and effector T cell populations. Furthermore, the vaccine exhibited a favorable safety profile in vivo with no significant toxicity observed. Our findings demonstrate a biomimetic vaccine design strategy integrating engineered vesicles with machine learning-assisted physicochemical analysis, providing a promising approach to combat monkeypox.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


